No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Cabergoline
-
Ergolines / therapeutic use*
-
Follow-Up Studies
-
Humans
-
Hyperprolactinemia / drug therapy*
-
Pituitary Neoplasms / drug therapy*
-
Pituitary Neoplasms / surgery
-
Prolactin / blood
-
Prolactinoma / drug therapy*
-
Prolactinoma / surgery
-
Recurrence
-
Withholding Treatment
Substances
-
Antineoplastic Agents
-
Ergolines
-
Prolactin
-
Cabergoline